The current financial score of Lifestance Health Group Inc is 9.28. Its financial status is robust, and its operating efficiency is high. Its latest quarterly revenue reached 435.35M, representing a year-over-year increase of 26.08%, while its net profit experienced a year-over-year increase of 722.84%.
The current valuation score of Lifestance Health Group Inc is 7.23. Its current P/E ratio is 209.64, which is 46.17% below the recent high of 306.43 and 249.45% above the recent low of -313.31.
The current earnings forecast score of Lifestance Health Group Inc is 8.00. The average price target is 13.40, with a high of 16.00 and a low of 7.00.
The current price momentum score of Lifestance Health Group Inc is 3.91. Currently, the stock price is trading between the resistance level at 13.45 and the support level at 11.80, making it suitable for range-bound swing trading.
The current institutional shareholding score of Lifestance Health Group Inc is 10.00. The latest institutional shareholding proportion is 101.39%, representing a quarter-over-quarter increase of 7.20%. The largest institutional shareholder is First Eagle Investment, holding a total of 1.56M shares, representing 0.03% of shares outstanding, with 50.67% increase in holdings.
The current risk assessment score of Lifestance Health Group Inc is 6.88. The company's beta value is 1.20. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.